Drug intelligence / Profile preview

ciprofloxacin + dexamethasone + N-acetyl cysteine

Development stage
Preclinical
Lead developer
Bayer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Otic
01

Overview

This is a combination drug consisting of ciprofloxacin, dexamethasone, and N-acetyl cysteine. Ciprofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, leading to the inhibition of bacterial replication and cell death. Dexamethasone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory properties; it reduces inflammation by suppressing multiple inflammatory cytokines and mediators. N-acetyl cysteine (NAC) acts as an antioxidant and mucolytic agent; it replenishes intracellular glutathione levels, scavenges reactive oxygen species, disrupts biofilms, and has demonstrated synergistic effects with antibiotics against resistant bacteria. This combination has been studied primarily for topical use in refractory ear infections (chronic suppurative otitis media or persistent otorrhea), where NAC augments the efficacy of ciprofloxacin/dexamethasone by enhancing antibacterial activity—especially against biofilm-forming pathogens such as Pseudomonas aeruginosa—and providing additional anti-inflammatory protection[1][2][6].

Other names
ciprofloxacin + dexamethasone + N-acetyl cysteineCiprodex + NACCiprodex + acetylcysteine
02

Targets

Topo IV (Bacterial Topoisomerase IV)GR (Glucocorticoid receptor)DNA gyrase

Beyond the preview

Go deeper on ciprofloxacin + dexamethasone + N-acetyl cysteine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciprofloxacin + dexamethasone + N-acetyl cysteine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call